Due to the error in the recording of correct amount of inventory the ,at the end of Madison river supply balance sheet , the inventory , current assets, total assets and shareholders equity would be understated by $10,400.
Now due to the error in recording correct amount of inventory , in the balance sheet it will be shown as understated by $10,400 ( $555,400 - $5454,000 ) , now because of this the current assets would become understated by the same amount as inventory comes under the current assets.
Since current assets are understated , the total assets of the company would also be understated and so do shareholders equity as the net income has decreased because of the increase in cost of goods sold.
Answer: cost of plastic = $168,000
excess cost = $3000
Explanation: This can be done as follows :-
cost of plastic = (standard quantity per * (standard price * ( no. of helmet)
should been helmet) per kg of plastic)
incurred
= (0.6) * (8) * (35,000)
= $168,000
so the extra cost incurred is $3000 that is $171,000 - $168,000 .
Answer:
If the company makes 8 deposits, one per year earning 7% per year, in order to get $375000 at the 8 year, the company has to deposit $34,874.16 each year.
Explanation:
To get this number the best option is to use a excel spreadsheet and solver add-in. In a table with 8 columns (8 years), organize the payments and the rule of interest: payment year 1*(1+7%)^8+payment year 2*(1+7%)^7+payment year 3*(1+7%)^6+payment year 4*(1+7%)^5+payment year 5*(1+7%)^4+payment year 6*(1+7%)^3+payment year 7*(1+7%)^2++payment year 8*(1+7%)^1 where all the payments are equal (payment 1=p2=p3...=P8)
Answer:
Place
Explanation:
The four Ps of the marketing mix are:
- price: Thad has already carried out a comparative price analysis
- place: ?????
- promotion: Thad already started developing a marketing strategy.
- product: Thad has already research his competitors' products and market trends. He also worked together with the product manager to add more color options.
Answer:
stock price will not change at all
Explanation:
Based on the information provided it can be said that when the company releases its next earnings report the stock price will not change at all. This is because stock markets move fast, the stock price of EPS moved when the in the announcement about FDA approval was made. Therefore the markets already expect these changes to reflect on the earnings report so prices will not move. Just as the saying goes, "Buy the Rumor, Sell the news."
